BioNxt Solutions (BNXTF) Financial Statements
BioNxt Solutions Financial Overview
BioNxt Solutions's market cap is currently $25.32M. The company's EPS TTM is $-0.07; its P/E ratio is -3.52; BioNxt Solutions has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 26.98K | $ 372.25K | $ 297.44K | $ 286.50K |
| Gross Profit | $ -10.90K | $ 26.98K | $ 372.25K | $ 195.62K | $ 199.48K |
| Operating Income | $ -6.05M | $ -4.45M | $ -6.37M | $ -6.04M | $ -16.31M |
| EBITDA | $ -6.04M | $ -4.32M | $ -6.48M | $ -11.51M | $ -19.19M |
| Net Income | $ -7.03M | $ -5.31M | $ -7.72M | $ -12.38M | $ -20.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 55.26K | $ 32.35K | $ 363.65K | $ 136.20K | $ 1.35M |
| Total Assets | $ 591.68K | $ 569.36K | $ 1.27M | $ 1.61M | $ 9.73M |
| Total Debt | $ 5.95M | $ 4.28M | $ 4.89M | $ 4.37M | $ 5.46M |
| Net Debt | $ 5.89M | $ 4.25M | $ 4.53M | $ 4.23M | $ 4.10M |
| Total Liabilities | $ 9.96M | $ 8.43M | $ 6.55M | $ 5.74M | $ 8.06M |
| Stockholders' Equity | $ -9.37M | $ -7.86M | $ -5.28M | $ -4.13M | $ 1.67M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.20M | $ -3.03M | $ -5.37M | $ -6.23M | $ -12.61M |
| Operating Cash Flow | $ -5.20M | $ -3.03M | $ -5.17M | $ -6.23M | $ -12.16M |
| Investing Cash Flow | $ 87.43K | $ 56.21K | $ 100.84K | $ -3.86K | $ -5.31M |
| Financing Cash Flow | $ 5.13M | $ 2.64M | $ 5.29M | $ 5.02M | $ 16.23M |
Currency in CAD
